Cardiac Resynchronization Therapy (CRT) Devices Market Size, Share and Trends Analysis | Global | 2022-2028 | MedCore | Includes: Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps), and 1 more

List of Tables

In 2021, the cardiac resynchronization therapy devices market was valued at $3.2 billion and is expected to increase at a CAGR of 4.3% to reach $4.3 billion by 2028.

Our research analyzed CRT companies from over 70 countries, providing valuable insights into market size, unit sales, and company market share. We used a thorough methodology to ensure accurate forecasts and provide a complete understanding of the CRT market. The report suite covers the global market for CRT devices, including CRT-P and CRT-D, providing a comprehensive overview of the industry.

MARKET REPORT DATA TYPES INCLUDED:

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2028, and Historical Data to 2018
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

PROCEDURE NUMBERS

The global ICD market encompasses single-chamber, dual-chamber, and S-ICD procedures for both initial placement and replacement. Despite the decline and subsequent recovery in 2020 and 2021 caused by delayed and cancelled elective procedures, the total number of ICD procedures is expected to grow at a moderate rate over the forecast period.

GLOBAL CRT MARKET TRENDS

In 2021, the CRT device market saw an increase from the previous year. Despite being the costliest device category in the CRM industry, the additional benefits offered by CRT-D devices compared to ICDs have made them appealing enough to overcome the price difference.

GLOBAL CPT MARKET SHARE INSIGHTS

The global CPT market is dominated by three major players: Medtronic, Abbott, and Boston Scientific. In 2021, Medtronic was the market leader in CRT devices, with a strong product line for both CRT-D and CRT-P, including the CobaltTM, CromeTM, SerenaTM, SolaraTM, and other devices.

GLOBAL CPT MARKET SEGMENTATION SUMMARY

Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps)
Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds)

RESEARCH SCOPE SUMMARY

Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

Base Year: 2021
Forecast: 2022-2028
Historical Data: 2018-2021

Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.

Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.

Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE IDATA?

Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

Product Code: iDATA_GLCRT22_MC

TABLE OF CONTENT

Cardiac Resynchronization Therapy Device Market

8.1. Executive Summary
- 8.1.1. Global Cardiac Resynchronization Therapy Device Market Overview
- 8.1.2. Competitive Analysis
- 8.1.3. Procedures Included
- 8.1.4. Markets Included
- 8.1.5. Regions Included
8.2. Introduction
- 8.2.1. Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps)
- 8.2.2. Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds)
8.3. Procedure Numbers
- 8.3.1. Total CRT Placement Procedures
- 8.3.2. Initial Placement CRT Procedures
- 8.3.3. Replacement CRT Procedures
8.4. Market Overview
- 8.4.1. By Segment
- 8.4.2. By Region
8.5. Market Analysis and Forecast
- 8.5.1. Total CRT Device Market
- 8.5.2. CRT-P Market
  - 8.5.2.1. Initial Placement CRT-P Market
  - 8.5.2.2. Replacement CRT-P Market
- 8.5.3. CRT-D Market
  - 8.5.3.1. Initial Placement CRT-D Market
  - 8.5.3.2. Replacement CRT-D Market
8.6. Drivers and Limiters
- 8.6.1. Market Drivers
- 8.6.2. Market Limiters
8.7. Competitive Market Share Analysis